STA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.
Published September 3, 2025 · Recall initiated: July 21, 2025
Summary
FDA records medical device Class II recall Z-2474-2025, published September 3, 2025 and initiated July 21, 2025. Recalling firm: Diagnostica Stago, Inc.; Status: Ongoing; Reported quantity: 116,600 units (114,600 US); Lot: Model/Catalog Number: 00311US. UDI-DI: 03607450011784. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diagnostica Stago, Inc.
- Distributor
- Worldwide - US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, LA, MD, ME, MN, MO, MT, NC, OH, OK, OR, PA, PR, SD, VT, WI, WY and the countries of Algeria, Argentina, Austria, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, France, French Polynesie, Guadeloupe, India, Iran, Israel, Jordan, Korea, Kuwait, Lebanon, Malaysia, Mexico, Morocco, Netherlands, Oman, Paraguay, Peru, Republique Tcheque, Romania, Saudi Arabia, Serbia, South Africa, Switzerland, Taiwan, Thailand, Tunisia, Turquie, United Arab Emirates, Uruguay, Vietnam.
- Lot
- Model/Catalog Number: 00311US. UDI-DI: 03607450011784.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASTA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitativeSeptember 9, 2026
- FDAAMERICAN CONTRACT SYSTEMS, Medical Procedure kits and trays labeled as: 1) ANTERIOR HIP PACK, MODEL/ITEMSeptember 3, 2025
- FDAMedline Kits containing BD SureStep Foley Tray Systems: SKU/Description: CDS984076J GYN ROBOTIC DYNJG001004ASeptember 3, 2025
- FDADiagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombinSeptember 19, 2018
- FDANeoplastine® Cl Plus ¿ (ref. 00375) Product Usage: Manual or automated determination of the prothrombin timeMarch 21, 2018
- FDASTA - Neoplastine® Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombinMarch 21, 2018
Questions about this recall
Was STA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate. recalled?
Yes. FDA published recall Z-2474-2025 on September 3, 2025. Reported hazard: Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail